Clinical Trial Update: Treatment Of Children With Short Stature At An Age Of 3-7 Years Who Were Born Small For Gestational Age [Phase 3]

View source ↗

Summary

Pfizer-sponsored Phase 3 trial evaluating treatment for children aged 3-7 with short stature who were born small for gestational age has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Growth Disorders
• Short Stature

Snippet

Sponsor: Pfizer | Conditions: Growth Disorders | Phase 3 | Status: COMPLETED